Biopharmaceutical
Medical
Pharmaceutical

Abeona Therapeutics

$3.72
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-0.53%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell ABEO and other stocks, options, ETFs, and crypto commission-free!

About ABEO

Abeona Therapeutics Inc. Common Stock, also called Abeona Therapeutics, is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life threatening rare diseases. Read More It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in New York, NY.

Employees
83
Headquarters
New York, New York
Founded
1974
Market Cap
179.33M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
550.33K
High Today
$3.77
Low Today
$3.64
Open Price
$3.72
Volume
278.70K
52 Week High
$15.65
52 Week Low
$3.64

Collections

Biopharmaceutical
Medical
Pharmaceutical
Health
Gene Therapies
Therapy
Technology
2015 IPO

ABEO News

Yahoo FinanceJun 23

Here’s What Hedge Funds Think About Abeona Therapeutics Inc

636

ABEO Earnings

-$0.40
-$0.32
-$0.23
-$0.15
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, After Hours

More ABEO News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.